Dr Daphne Collias


Daphne obtained her PhD in Chemical and Biomolecular Engineering from North Carolina State University (NCSU). For her PhD, she studied DNA targeting requirements and outcomes for CRISPR technologies in Chase’s former lab at NCSU and as a visiting student in Chase’s lab at HIRI. Her current research focuses on the development of a new CRISPR-based diagnostic platform since joining the lab as a postdoc in February 2021.